| Condensed Consolidated Statements Of Operations | |
| Net revenue | |
| Cost of sales | 643M |
| Gross margin | 445M |
| Research and development | 312M |
| Marketing, general and administrative | 179M |
| Amortization of acquired intangible assets | |
| Restructuring reversals | 47M |
| Operating income | -98M |
| Interest income | 1M |
| Interest expense | -44M |
| Other income (expense), net | -3M |
| Income before equity income (loss) and dilution gain in investee and income taxes | -144M |
| Provision (benefit) for income taxes | 2M |
| Equity income (loss) and dilution gain in investee, net | |
| Net income (loss) | |
| Net income (loss) per share | |
| Basic | -0.19 |
| Diluted | -0.19 |
| Shares used in per share calculation | |
| Basic | 749M |
| Diluted | 749M |